Post-doctoral position at the Institute of Genetics and Molecular and Cellular Biology (Illkirch, France) in the team of Daniel Metzger

Project : “Identification of new biomarkers and drug targets for prostate cancer

Prostate cancer (PCa) is the second most commonly diagnosed neoplasia in men worldwide and one of the major causes of cancer-related death in men. Advances made in the management of PCa have markedly improved survival rates in men with localized disease, but current treatments have considerable side effects. Moreover, no reliable biomarkers are available to predict relapses, and patients with metastatic disease have limited treatment options and an overall poor prognosis.
Our laboratory generated Pten(i)pe−/− mice, in which the tumor suppressor gene Pten is selectively ablated in luminal prostatic epithelial cells at adulthood. We have shown that these mice faithfully recapitulate disease progression in humans, and are valuable tools to provide insights in prostate tumorigenesis. Our recent results based on single cell transcriptomics and histological analyses revealed that the evolution of prostatic tumors is associated with luminal epithelial cell plasticity and immunosuppression.
The aim of the project is to characterize the underlying molecular mechanisms, identify new biomarkers of tumor evolution and new drug targets, using cutting-edge technics.

We offer a 2-year contract, starting October 2022, with the possibility of extension.

Requirements

Applicants should have a PhD in biological science, a strong background in cellular and molecular biology with a sound knowledge in cancer research and genetics. Expertise in bioinformatics will be a plus.

Your responsibilities will include:

  • Molecular biological assays on tissues of genetically modified mice
  • Organoid cultures
  • Single cell RNAseq and spatial single cell RNAseq analyses of mouse and human prostate tumors
  • Mentoring graduate and undergraduate trainees

Your application

Candidates should send a curriculum vitae with a publication list, a short summary of research achievements and mastered techniques, as well as contact information of at least two references to .

 

More information

 


Appels à projets

  • Fondation ARC
    Date limite dépôt dossier : 18/03/2025

    Appel à projets SIGN’IT 2025

  • INCA, IReSP
    Date limite dépôt dossier : 20/03/2025

    Conduites addictives et drogues

  • Ligue contre le cancer
    Date limite dépôt dossier : 27/03/2025

    Subventions pour l’organisation de colloques scientifiques

  • GIRCI Est
    Date limite dépôt lettre d’intention : 27/03/2025

    Appel à projets J’InvEST-I

  • GIRCI Est
    Date limite dépôt lettre d’intention : 27/03/2025

    Appel à projets APPARA

  • INCA
    Date limite dépôt dossier : 10/04/2025

    Subventions doctorales / Recherche sur les conduites addictives et drogues

  • GIRCI Est
    Date limite dépôt lettre d’intention : 11/04/2025

    Appel à projets ReSP-Ir

  • Ligue contre le cancer
    Date limite dépôt dossier : 16/04/2025

    Appel à Projets Recherche-Action 2025

  • INCA
    Date limite dépôt dossier : 14/05/2025

    Appel à projets 2025 - Agir en santé publique

  • Cancéropôle Est
    Date limite dépôt dossier : 15/05/2025

    Soutien à la participation à des congrès internationaux

  • Cancéropôle Est
    Date limite dépôt dossier : 15/05/2025

    Soutien aux manifestations scientifiques

  • Cancéropôle Est
    Date limite dépôt dossier : 15/05/2025

    Soutien mobilité nationale

Agenda

13-14 mars 2025

1res journées d’immuno-oncologie du Cancéropôle Est

16 mai 2025
Date limite pour s’inscrire : 15/03/2025

1e journée Hémopathies à pDC (LpDC et LAM-pDC, MPDCP)

11-15 mai 2025
Date limite pour déposer un résumé : 16/03/2025

FEBS Advanced Lecture Course 2025 - PARP2025: from molecular aspects to medical applications